FDA probes accuracy issue with Abbott's rapid virus test
Researchers at New York University reported results suggesting Abbott's test can miss up to half the infections caught by a rival test made by Cepheid
Researchers at New York University reported results suggesting Abbott's test can miss up to half the infections caught by a rival test made by Cepheid